Julia Bascom is executive director of the Autistic Self Advocacy Network.
Julia Bascom
Executive director
Autistic Self Advocacy Network
From this contributor
The DSM-5 has not improved services for autistic adults
Since the DSM-5’s debut, schoolchildren have gained stronger legal rights and better opportunities for accessing services; for adults, it’s a different story.
The DSM-5 has not improved services for autistic adults
By
Julia Bascom
9 May 2018 | 5 min read
Why intelligence scores do not predict success for autistic adults
Measures of adaptive functioning may better assess the ability of autistic people to meet daily demands than do intelligence tests.
Why intelligence scores do not predict success for autistic adults
By
Julia Bascom, Gregory Wallace
28 November 2017 | 6 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read